Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (251-260 of 325) with videos related to

Pageof 33
Sort By:
Archives of Internal Medicine|May 10, 2006
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopneaNajib T Ayas, J Mark FitzGerald, John A Fleetham, et al.
Plos One|April 5, 2013
Bronchodilator responsiveness and reported respiratory symptoms in an adult populationWan C Tan, Jean Bourbeau, Paul Hernandez, et al.
Clinical Therapeutics|August 27, 2019
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX StudySandhya Khurana, Guy G Brusselle, Elisabeth H Bel, et al.
Lancet (London, England)|September 10, 2016
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trialJ Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, et al.
The European Respiratory Journal|May 30, 2015
Bronchial thermoplasty in asthma: 2-year follow-up using optical coherence tomographyMiranda Kirby, Keishi Ohtani, Rosa Maria Lopez Lisbona, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 2017
Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic ResponseAmrit Singh, Casey P Shannon, Young Woong Kim, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2018
Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease HospitalizationsFernando Sergio Leitao Filho, Nawaf M Alotaibi, David Ngan, et al.
Pragmatic and Observational Research|March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional AnalysisAndrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
Chest|February 16, 2010
A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interactionSmita Pakhale, Steve Doucette, Katherine Vandemheen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2022
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma PhenotypeKlaus F Rabe, J Mark FitzGerald, Eric D Bateman, et al.
Pageof 33

Showing results (251-260 of 325) with videos related to

Sort By:
Pageof 33
Archives of Internal Medicine|May 10, 2006
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopneaNajib T Ayas, J Mark FitzGerald, John A Fleetham, et al.
Plos One|April 5, 2013
Bronchodilator responsiveness and reported respiratory symptoms in an adult populationWan C Tan, Jean Bourbeau, Paul Hernandez, et al.
Clinical Therapeutics|August 27, 2019
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX StudySandhya Khurana, Guy G Brusselle, Elisabeth H Bel, et al.
Lancet (London, England)|September 10, 2016
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trialJ Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, et al.
The European Respiratory Journal|May 30, 2015
Bronchial thermoplasty in asthma: 2-year follow-up using optical coherence tomographyMiranda Kirby, Keishi Ohtani, Rosa Maria Lopez Lisbona, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 2017
Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic ResponseAmrit Singh, Casey P Shannon, Young Woong Kim, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2018
Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease HospitalizationsFernando Sergio Leitao Filho, Nawaf M Alotaibi, David Ngan, et al.
Pragmatic and Observational Research|March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional AnalysisAndrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
Chest|February 16, 2010
A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interactionSmita Pakhale, Steve Doucette, Katherine Vandemheen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2022
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma PhenotypeKlaus F Rabe, J Mark FitzGerald, Eric D Bateman, et al.
Pageof 33